This inventor holds 1 USPTO granted patent. Top assignee: Eyegene Inc.. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Kyoung Chul Ko: Innovator in Retinopathy Treatment
Introduction
Kyoung Chul Ko is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of medical treatments, particularly in addressing eye conditions such as retinopathy and glaucoma. His innovative work has led to the development of a unique composition that utilizes thrombin-derived peptides.
Latest Patents
Kyoung Chul Ko holds 1 patent for his invention titled "Composition for treating retinopathy or glaucoma comprising thrombin derived peptides." This patent discloses a composition that effectively treats retinopathy by incorporating thrombin-derived peptides as a key component.
Career Highlights
Kyoung Chul Ko is currently associated with Eyegene Inc., a company that focuses on advancing medical technologies and treatments. His role at Eyegene Inc. allows him to contribute to innovative solutions in the healthcare sector.
Collaborations
Kyoung Chul Ko has collaborated with notable colleagues, including Jin Wook Jang and Hyeong Joon Lim. These partnerships enhance the research and development efforts within his field.
Conclusion
Kyoung Chul Ko's work exemplifies the impact of innovation in medical treatments, particularly for eye diseases. His contributions continue to pave the way for advancements in healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile